Patent ID: 8853159

Claim:
A fusion peptide comprising a component (I) N-terminally having a sequence according to formula I: His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-X(I) (SEQ ID NO: 43), wherein X is NH 2 or Gly-OH, or a sequence having 95% sequence identity with SEQ ID NO: 43; a component (II) C-terminally having a peptide sequence containing SEQ ID NO: 22 or sequence having 90% sequence identity with SEQ ID NO: 22 (RRDFPEEVAI); and a component (III) C-terminally having a sequence according to formula I (SEQ ID NO: 43) or a sequence having 95% sequence identity with SEQ ID NO: 43; and its pharmaceutically active salts.